罗万特科学

最新新闻

• 评级变动
  Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/5/26
• 评级变动
  J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• Bernstein Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $41
  \u5e02\u573a\u8d44\u8baf · 2026/9/27
• 公司公告
  Roivant Sciences: Roivant Sciences Ltd. - Flex Position Consolidation Option Symbol: 1ROIV
  OCC · 2026/5/11
• Stifel Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $51
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• Form 144 | Roivant Sciences(ROIV.US) Officer Proposes to Sell 7.32 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $46
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/28
• 评级变动
  H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• Roivant Sciences(ROIV.US) Officer Sells US$7.32 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  Stifel Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $51
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $41
  \u5e02\u573a\u8d44\u8baf · 2026/8/28
• J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $46 to $55
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $34 to $42
  \u5e02\u573a\u8d44\u8baf · 2026/5/22

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。